|
|
Logo
Logo Logo

Category Archives: "News"

  1. Home
  2. INforMS
  3. Page 31
Jun 07, 2016
‘Multiple sclerosis does not remit’ – call to change RRMS name to relapsing multiple sclerosis
INforMS, MS Community
MS does not remit and the out dated term causes many people to delay taking medication, says Dr Patricia Coyle, Founder and Director of [...]
Elizabeth Porco
Read More
...19
0
Jun 07, 2016
CMSC 2016 Annual Meeting – multiple sclerosis mice show reduced disease severity after treatment with vegetable compound
CMSC PR
Research from Indiana University School of Medicine showed that D3T – a compound that triggers copying of antioxidant genes and [...]
Elizabeth Porco
Read More
...17
0
Jun 07, 2016
CMSC 2016 Annual Meeting – multiple sclerosis patients, physical therapists have distinct decision-making processes
CMSC PR, Partners
Understanding and combining decision-making processes of both patients with multiple sclerosis (MS) and physical therapists to improve [...]
Elizabeth Porco
Read More
...21
0
Jun 07, 2016
CMSC 2016 Annual Meeting – home DVD-guided exercise may help older multiple sclerosis patients
CMSC PR
Positive results from a home-based exercise intervention designed to target flexibility, toning, and balance for older adults with multiple [...]
Elizabeth Porco
Read More
...19
0
Jun 07, 2016
CMSC 2016 Annual Meeting – multiple sclerosis duration and disability level variously impacts arm function
CMSC PR, Partners
Most research in multiple sclerosis (MS) has focused on the impact of the disease on the lower extremities. To balance this, researchers [...]
Elizabeth Porco
Read More
...18
0
Jun 06, 2016
CMSC 2016 Annual Meeting – multiple sclerosis and yoga: author and instructor says ancient discipline can help patients
CMSC PR, Partners
Mindy Eisenberg is the author of the book “Adaptive Yoga Moves Any Body” and Multiple Sclerosis News Today had the chance to hear [...]
Elizabeth Porco
Read More
...17
0
Jun 06, 2016
CMSC 2016 Annual Meeting – Ocrevus (Ocrelizumab) in PPMS prevented disability progression
CMSC PR, Partners
Data recently presented at the Consortium of Multiple Sclerosis Centers (CMSC) 2016 Annual Meeting showed that Roche/Genentech’s [...]
Elizabeth Porco
Read More
...17
0
Jun 06, 2016
CMSC 2016 Annual Meeting – Genentech’s Ocrelizumab a promising therapy for primary progressive multiple sclerosis
CMSC PR
Genentech, a member of the Roche Group, was founded more than 35 years ago and has been focused on a variety of research fields, including [...]
Elizabeth Porco
Read More
...17
0
Jun 06, 2016
CMSC 2016 Annual Meeting – RRMS patients’ five-year clinical outcome improved – find out how
CMSC PR
Results from a Phase 2 clinical trial showed that five-year clinical outcomes of patients with highly active relapsing-remitting multiple [...]
Elizabeth Porco
Read More
...16
0
Jun 06, 2016
CMSC 2016 Annual Meeting – strive study confirms Tysabri safety in early relapsing-remitting multiple sclerosis
CMSC PR
Results from the STRIVE study support the safety of natalizumab (Tysabri) as a therapy for multiple sclerosis (MS) patients. The study, [...]
Elizabeth Porco
Read More
...19
0
  • (201) 487-1050
  • 3 University Plz Dr Ste 116, Hackensack, NJ 07601
  • info@mscare.org

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us
I have a question about
First
Last